CG MedTech (056090)

KOSDAQ · 1,159 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

1,0001,5002,0002,5003,000 H 3,350L 864 25.0826.0526.08
Mkt Cap
119.7B
Rev (2025)
47.2B
Op Inc (2025)
3.8B
Net Inc (2025)
6.5B
PBR
1.27
52W
0K~3K

CG MedTech operates in the Medical, Precision & Optical sector.

Legal name: CG MedTech Co.,Ltd.

In fiscal year 2025, CG MedTech (056090) reported revenue of 47.2 billion KRW, up 36.4% from 34.6 billion KRW a year earlier.

Operating profit was 3.8 billion KRW and net income was 6.5 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 119.7 billion KRW, with a P/B of 1.27.

These figures can be verified in the DART filing (receipt no. 20260320001211).

Financials

YearRevOp IncNet Inc
202547.2B3.8B6.5B
202434.6B-1.1B-125M
202335.0B-1.6B1.3B

Full financials →

Checks

0 applicable out of 8 items

Check details →

Recent Filings

Semi-Annual Report (2026.06)

Extraordinary Meeting Result

Officer/Major Shareholder Trading Plan Report

All filings →

Checks

No items require attention at this time.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: No administrative designation criteria met.

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: No convertible bonds outstanding.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-14Semi-Annual Report (2026.06)
2026-08-11Extraordinary Meeting Result
2026-08-04Officer/Major Shareholder Trading Plan Report